Up-regulated dicer expression in patients with cutaneous melanoma

PLoS ONE

Volumn 6, Issue 6, 2011, Pages

  Ma, Zhihai ^a   Swede, Helen ^b   Cassarino, David ^c   Fleming, Elizabeth ^b   Fire, Andrew ^a   Dadras, Soheil S ^b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^c KAISER PERMANENTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DICER; MESSENGER RNA; RIBONUCLEASE III;

ARTICLE; CANCER INVASION; CANCER STAGING; CARCINOMA; CONTROLLED STUDY; CUTANEOUS MELANOMA; ENZYME ACTIVITY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MELANOCYTIC NEVUS; MELANOMA; MITOSIS INDEX; PROTEIN EXPRESSION; SARCOMA; UPREGULATION; WESTERN BLOTTING; CELL LINE; GENETICS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN TUMOR;

CELL LINE; HUMANS; IMMUNOHISTOCHEMISTRY; MELANOMA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RIBONUCLEASE III; SKIN NEOPLASMS; UP-REGULATION;

EID: 79959320865     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0020494     Document Type: Article

References (35)

1. Bartel DP, (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
2. Ryan BM, Robles AI, Harris CC, (2010) Genetic variation in microRNA networks: the implications for cancer research. Nat Rev Cancer 10: 389-402.
3. Doench JG, Petersen CP, Sharp PA, (2003) siRNAs can function as miRNAs. Genes Dev 17: 438-442.
4. Esquela-Kerscher A, Slack FJ, (2006) Oncomirs- microRNAs with a role in cancer. Nat Rev Cancer 6: 259-269.
5. Calin GA, Liu CG, Sevignani C, Ferracin M, Felli N, et al. (2004) MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias. Proc Natl Acad Sci U S A 101: 11755-11760.
6. Takamizawa J, Konishi H, Yanagisawa K, Tomida S, Osada H, et al. (2004) Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res 64: 3753-3756.
7. Michael MZ, van Holst Pellekaan NG, Young GP, James RJ, (2003) Reduced accumulation of specific microRNAs in colorectal neoplasia. Mol Cancer Res 1: 882-891.
8. Roldo C, Missiaglia E, Hagan JP, Falconi M, Capelli P, et al. (2006) MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors are associated with distinctive pathologic features and clinical behavior. J Clin Oncol 24: 4677-4684.
9. Mueller DW, Rehli M, Bosserhoff AK, (2009) miRNA expression profiling in melanocytes and melanoma cell lines reveals miRNAs associated with formation and progression of malignant melanoma. J Invest Dermatol 129: 1740-1751.
10. Stark MS, Tyagi S, Nancarrow DJ, Boyle GM, Cook AL, et al. (2010) Characterization of the Melanoma miRNAome by Deep Sequencing. PLoS One 5: e9685.
11. Caramuta S, Egyhazi S, Rodolfo M, Witten D, Hansson J, et al. (2010) MicroRNA expression profiles associated with mutational status and survival in malignant melanoma. J Invest Dermatol 130: 2062-2070.
12. Segura MF, Belitskaya-Levy I, Rose AE, Zakrzewski J, Gaziel A, et al. (2010) Melanoma MicroRNA signature predicts post-recurrence survival. Clin Cancer Res 16: 1577-1586.
13. Ma Z, Lui WO, Fire A, Dadras SS, (2009) Profiling and discovery of novel miRNAs from formalin-fixed, paraffin-embedded melanoma and nodal specimens. J Mol Diagn 11: 420-429.
14. Jukic DM, Rao UN, Kelly L, Skaf JS, Drogowski LM, et al. (2010) Microrna profiling analysis of differences between the melanoma of young adults and older adults. J Transl Med 8: 27.
15. Hammond SM, (2005) Dicing and slicing: the core machinery of the RNA interference pathway. FEBS Lett 579: 5822-5829.
16. Chiosea S, Jelezcova E, Chandran U, Acquafondata M, McHale T, et al. (2006) Up-regulation of dicer, a component of the MicroRNA machinery, in prostate adenocarcinoma. Am J Pathol 169: 1812-1820.
17. Chiosea S, Jelezcova E, Chandran U, Luo J, Mantha G, et al. (2007) Overexpression of Dicer in precursor lesions of lung adenocarcinoma. Cancer Res 67: 2345-2350.
18. Merritt WM, Lin YG, Han LY, Kamat AA, Spannuth WA, et al. (2008) Dicer, Drosha, and outcomes in patients with ovarian cancer. N Engl J Med 359: 2641-2650.
19. Balch CM, Gershenwald JE, Soong SJ, Thompson JF, Atkins MB, et al. (2009) Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol 27: 6199-6206.
20. Dadras SS, Paul T, Bertoncini J, Brown LF, Muzikansky A, et al. (2003) Tumor lymphangiogenesis: a novel prognostic indicator for cutaneous melanoma metastasis and survival. Am J Pathol 162: 1951-1960.
21. Scatolini M, Grand MM, Grosso E, Venesio T, Pisacane A, et al. (2010) Altered molecular pathways in melanocytic lesions. International journal of cancer Journal international du cancer 126: 1869-1881.
22. Riker AI, Enkemann SA, Fodstad O, Liu S, Ren S, et al. (2008) The gene expression profiles of primary and metastatic melanoma yields a transition point of tumor progression and metastasis. BMC medical genomics 1: 13.
23. Tokumaru S, Suzuki M, Yamada H, Nagino M, Takahashi T, (2008) let-7 regulates Dicer expression and constitutes a negative feedback loop. Carcinogenesis 29: 2073-2077.
24. Nakagawa A, Shi Y, Kage-Nakadai E, Mitani S, Xue D, (2010) Caspase-dependent conversion of Dicer ribonuclease into a death-promoting deoxyribonuclease. Science 328: 327-334.
25. Levy C, Khaled M, Robinson KC, Veguilla RA, Chen PH, et al. (2010) Lineage-specific transcriptional regulation of DICER by MITF in melanocytes. Cell 141: 994-1005.
26. Ihara Y, Kato Y, Bando T, Yamagishi F, Minamimura T, et al. (2002) Allelic imbalance of 14q32 in esophageal carcinoma. Cancer Genet Cytogenet 135: 177-181.
27. Shao J, Li Y, Wu Q, Liang X, Yu X, et al. (2002) High frequency loss of heterozygosity on the long arms of chromosomes 13 and 14 in nasopharyngeal carcinoma in Southern China. Chin Med J (Engl) 115: 571-575.
28. Tzai TS, Chen HH, Chan SH, Ho CL, Tsai YS, et al. (2003) Clinical significance of allelotype profiling for urothelial carcinoma. Urology 62: 378-384.
29. Zhang L, Huang J, Yang N, Greshock J, Megraw MS, et al. (2006) microRNAs exhibit high frequency genomic alterations in human cancer. Proc Natl Acad Sci U S A 103: 9136-9141.
30. Karube Y, Tanaka H, Osada H, Tomida S, Tatematsu Y, et al. (2005) Reduced expression of Dicer associated with poor prognosis in lung cancer patients. Cancer Sci 96: 111-115.
31. Sugito N, Ishiguro H, Kuwabara Y, Kimura M, Mitsui A, et al. (2006) RNASEN regulates cell proliferation and affects survival in esophageal cancer patients. Clin Cancer Res 12: 7322-7328.
32. Muralidhar B, Goldstein LD, Ng G, Winder DM, Palmer RD, et al. (2007) Global microRNA profiles in cervical squamous cell carcinoma depend on Drosha expression levels. J Pathol 212: 368-377.
33. Chiosea SI, Barnes EL, Lai SY, Egloff AM, Sargent RL, et al. (2008) Mucoepidermoid carcinoma of upper aerodigestive tract: clinicopathologic study of 78 cases with immunohistochemical analysis of Dicer expression. Virchows Arch 452: 629-635.
34. Jakymiw A, Patel RS, Deming N, Bhattacharyya I, Shah P, et al. (2010) Overexpression of dicer as a result of reduced let-7 MicroRNA levels contributes to increased cell proliferation of oral cancer cells. Genes Chromosomes Cancer 49: 549-559.
35. Sand M, Gambichler T, Sand D, Altmeyer P, Stuecker M, Bechara FG, Immunohistochemical expression patterns of the microRNA-processing enzyme Dicer in cutaneous malignant melanomas, benign melanocytic nevi and dysplastic melanocytic nevi. Eur J Dermatol. 21 (1): 18-21 2011 1-2 1.